34 / 168
1.4
I
STATEMENT OF SHAREHOLDERS’ EQUITY
(in €’000)
Share capital
Capital-linked
premiums (Note 7.3)
Treasury shares
Consolidated
reserves
Conversion reserves
Other income
and expenses
recorded directly as
shareholders' equity
Profit for the period,
Group share
Group's share of
shareholders' equity
Minority interests
Total shareholders'
equity
SHAREHOLDERS’ EQUITY
AT JANUARY 1, 2016
RESTATED
21,610 72,584 (14,740)
603,092 30,598
(2,652)
81,764 792,257
1,189 793,445
Profit (loss) for the period N (A)
107,008 107,008
(619)
106,389
Translation differences (B)
(2,856)
(2,856)
(18)
(2,874)
Payments in shares (C)
1,604
1,604
1,604
Capital increase
0
0
0 3,947
3,947
Restatement of treasury
shares (D)
130
95
225
225
Restatement as per IAS19 (G)
(3,519)
(3,519)
(3,519)
Appropriation of N-1 earnings
81,764
(81,764)
0
0
Change in scope
0
512
513
Dividends distributed
(20,629)
(20,629)
0 (20,629)
Reclassifications
0
0
Fair value of hedging
instruments (F)
(8,980)
(8,980)
(48)
(9,028)
Various (E)
(4,852)
(4,852)
(4,852)
SHAREHOLDERS’ EQUITY
AT DECEMBER 31, 2016 21,610 72,584 (14,610)
660,979 27,742 (15,056)
107,008 860,258 4,964 865,222
INCLUDING TOTAL REVENUES
AND EXPENSES POSTED
FOR THE PERIOD
(A) + (B) + (C) + (D) + (E) + (F)+ (G)
(2,856)
(12,405)
107,008
91,747
(685)
91,063
SHAREHOLDERS’ EQUITY
AT JANUARY 1, 2017 21,610 72,584 (14,610)
659,375 27,742 (13,452)
107,008 860,258 4,964 865,222
Profit (loss) for the period N (A)
107,965 107,965 (1,014)
106,951
Translation differences (B)
(19,324)
(19,324)
73
(19,251)
Payments in shares (C)
2,075
2,075
2,075
Capital increase
0
0
0 2,000
2,000
Restatement of treasury
shares (D)
(110)
156
46
46
Restatement as per IAS19 (G)
369
369
369
Appropriation of N-1 earnings
107,008
(107,008)
0
0
Change in scope
(57,244)
(57,244)
0 (57,244)
Dividends distributed
(23,872)
(23,872)
0 (23,872)
Reclassifications
0
0
Fair value of hedging
instruments (F)
18,188
18,188
86
18,274
Various (E)
1,540
1,540 1,556
3,096
SHAREHOLDERS’ EQUITY
AT DECEMBER 31, 2017 21,610 72,584 (14,720)
688,882 8,419
5,261
107,965 890,001
7,664 897,665
INCLUDING TOTAL REVENUES
AND EXPENSES POSTED
FOR THE PERIOD
(A) + (B) + (C) + (D) + (E) + (F) + (G)
(19,324)
18,713 107,965 107,355 (855)
106,500
34
LISI 2017 FINANCIAL REPORT
CONSOLIDATED FINANCIAL STATEMENTS
3